Comparison of Corneal Epithelial Wound Healing between Topical RCI001, Solcoseryl, and Polydeoxyribonucleotide in the Murine Ocular Alkali Burn Model
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To compare the corneal epithelial wound healing effects of RCI001, Solcoseryl, and polydeoxyribonucleotide (PDRN)in a rat alkali burn model. Methods: In 40 male Sprague-Dawley rats, we induced alkali burn using filter paper soaked in 0.2N sodium hydroxide. Therats were then treated with topical 0.5% RCI001, 1.0% RCI001, Solcoseryl, or PDRN twice a day for 2 weeks. Corneal epithelialintegrity and epithelial healing rate were measured at day 0, 3, 5, 7, 10, and 14. Histologic and immunohistochemistry findingswere also assessed. Results: Both the 0.5% and 1.0% RCI001 groups showed significantly more epithelial healing compared to the control groupat day 5, 7, 10, and 14 (each p < 0.05). No statistical difference was found between the 0.5% and 1.0% RCI001 groups. Neitherthe Solcoseryl nor the PDRN groups showed a significant difference from the control. RCI001 treatment resulted in significantlyreduced stromal edema, and a trend towards less inflammatory cell infiltration. Conclusions: Topical application of RCI001 showed enhanced corneal epithelial wound healing in the murine corneal alkaliburn model, presumably by suppressing inflammation. Meanwhile, Solcoseryl and PDRN did not show sufficient therapeuticeffects compared to RCI001.
Abstract
Purpose: To compare the corneal epithelial wound healing effects of RCI001, Solcoseryl, and polydeoxyribonucleotide (PDRN)in a rat alkali burn model. Methods: In 40 male Sprague-Dawley rats, we induced alkali burn using filter paper soaked in 0.2N sodium hydroxide. Therats were then treated with topical 0.5% RCI001, 1.0% RCI001, Solcoseryl, or PDRN twice a day for 2 weeks. Corneal epithelialintegrity and epithelial healing rate were measured at day 0, 3, 5, 7, 10, and 14. Histologic and immunohistochemistry findingswere also assessed. Results: Both the 0.5% and 1.0% RCI001 groups showed significantly more epithelial healing compared to the control groupat day 5, 7, 10, and 14 (each p < 0.05). No statistical difference was found between the 0.5% and 1.0% RCI001 groups. Neitherthe Solcoseryl nor the PDRN groups showed a significant difference from the control. RCI001 treatment resulted in significantlyreduced stromal edema, and a trend towards less inflammatory cell infiltration. Conclusions: Topical application of RCI001 showed enhanced corneal epithelial wound healing in the murine corneal alkaliburn model, presumably by suppressing inflammation. Meanwhile, Solcoseryl and PDRN did not show sufficient therapeuticeffects compared to RCI001.
참고문헌 (46)
- Agrawal VB, "Corneal epithelial wound healing", Indian J Ophthalmol, 51, pp.5~15 (2003)
- Wilson SE, "Corneal wound healing", Exp Eye Res, 197, pp.108089~ (2020)
- Ljubimov AV, "Progress in corneal wound healing", Prog Retin Eye Res, 49, pp.17~45 (2015)
- Krannig HM, "Therapy of corneal erosions and ‘dry eye’ with Solcoseryl and Vitasic eye drops", Ophthalmologica, 199, pp.100~105 (1989)
- Lazzarotto M, "Clinical evaluation of corneal epithelialization after photorefractive keratectomy in a patient treated with Polydeoxyribonucleotide (PDRN) eye drops: a randomized, double-blind, placebo-controlled trial", Eur J Ophthalmol, 14, pp.284~289 (2004)
- Wilmink JM, "The effectiveness of the haemodialysate Solcoseryl for second-intention wound healing in horses and ponies", J Vet Med A Physiol Pathol Clin Med, 47, pp.311~320 (2000)
- Nam SM, "Wound healing and mucin gene expression of human corneal epithelial cells treated with deproteinized extract of calf blood", Curr Eye Res, 44, pp.1181~1188 (2019)
- Erbe W, "Our experience with Solcoseryl Eye-Gel in the treatment of corneal lesions : a randomised double-blind study(with 1 color plate)", Ophthalmologica, 188, pp.1~4 (1984)
- Studer O, "A comparative clinical study of Solcoseryl Eye-Gel and Cysteine Eye-Gel 2.4% in the treatment of foreign-body injuries of the cornea", Ophthalmic Res, 16, pp.179~184 (1984)
- Egger SF, "Corneal wound healing after superficial foreign body injury : vitamin A and dexpanthenol versus a calf blood extract : a randomized double-blind study", Ophthalmologica, 213, pp.246~249 (1999)
- Squadrito F, "Pharmacological activity and clinical use of PDRN", Front Pharmacol, 8, pp.224~ (2017)
- Kim S, "Investigating the anti-inflammatory effects of RCI001 for treating ocular surface diseases : insight into the mechanism of action", Front Immunol, 13, pp.850287~ (2022)
- Chernikov AV, "Exogenous 8-Oxo-7,8-dihydro-2’-deoxyguanosine: biomedical properties, mechanisms of action, and therapeutic potential", Biochemistry(Mosc), 82, pp.1686~1701 (2017)
- Im ST, "Therapeutic effects of topical 8-Oxo-2’-deoxyguanosine on ethanol-induced ocular chemical injury models", Cornea, 37, pp.1311~1317 (2018)
- Kim DH, "Comparison of therapeutic effects between topical 8-oxo-2’-deoxyguanosine and corticosteroid in ocular alkali burn model", Sci Rep, 11, pp.6909~ (2021)
- Kim DH, "Therapeutic effects of topical RCI001 on environmental and inflammation-related dry eye mouse models", Invest Ophthalmol Vis Sci, 62, pp.1322~ (2021)
- Oh JY, "Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury", Proc Natl Acad Sci U S A, 107, pp.16875~16880 (2010)
- Choy EP, "A novel porcine dry eye model system(pDEM)with simulated lacrimation", blinking system : preliminary findings on system variability and effect of corneal drying, 2004, pp.28, 319~325
- Kubota M, "Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model", Invest Ophthalmol Vis Sci, 52, pp.427~433 (2011)
- Wilson SE, "The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells", Prog Retin Eye Res, 20, pp.625~637 (2001)
- Gu XJ, "Involvement of NADPH oxidases in alkali burn-induced corneal injury", Int J Mol Med, 38, pp.75~82 (2016)
- Fortingo N, "Innate immune system activation, inflammation and corneal wound healing", Int J Mol Sci, 23, pp.14933~ (2022)
- Zieske JD, "Protein synthesis during corneal epithelial wound healing", Invest Ophthalmol Vis Sci, 27, pp.1~7 (1986)
- Panjwani N, "Neutral glycolipids of migrating and nonmigrating rabbit corneal epithelium in organ and cell culture", Invest Ophthalmol Vis Sci, 31, pp.689~695 (1990)
- Stepp MA, "Corneal integrins and their functions", Exp Eye Res, 83, pp.3~15 (2006)
- Carter RT, "The role of integrins in corneal wound healing", Vet Ophthalmol 2009;12 Suppl, 1, pp.2~9
- Zernii EY, "Therapeutic proteins for treatment of corneal epithelial defects", Curr Med Chem, 26, pp.517~545 (2019)
- Wilson SE, "Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis : a paradigm for fibrosis in other organs?", Matrix Biol, 64, pp.17~26 (2017)
- Vaidyanathan U, "Persistent corneal epithelial defects : a review article", Med Hypothesis Discov Innov Ophthalmol, 8, pp.163~176 (2019)
- Isler H, "Topical treatment of standardized burns with a protein-free haemodialysate", Burns, 17, pp.93~97 (1991)
- Isler H, "Morphometric assessment of wound healing in rats treated with a protein-free haemodialysate", Burns, 17, pp.99~103 (1991)
- Konturek SJ, "Comparison of solcoseryl and epidermal growth factors(EGF)in healing of chronic gastroduodenal ulcerations and mucosal growth in rats", Hepatogastroenterology, 35, pp.25~29 (1988)
- Niinikoski J, "Effect of a hexosylceramide fraction of the hemodialysate Solcoseryl on wound-healing angiogenesis", J Surg Res, 40, pp.261~264 (1986)
- Hoon Kim, "Effect of Solcoseryl in Corneal Alkali Burn Rat Model", Medical Lasers, 10(1), pp.22~30 (2021), 대한의학레이저학회[DOI]
- Choi JS, "Polydeoxyribonucleotide(PDRN)inhibits corneal inflammation in experimental rat keratoconjunctivitis sicca model", Invest Ophthalmol Vis Sci, 57, pp.5730~ (2016)
- Edirisinghe SL, "Effect of polydeoxyribonucleotide(PDRN)treatment on corneal wound healing in Zebrafish(Danio rerio)", Int J Mol Sci, 23, pp.13525~ (2022)
- Ko SH, "8-Oxo-2’-deoxyguanosine ameliorates features of metabolic syndrome in obese mice", Biochem Biophys Res Commun, 443, pp.610~616 (2014)
- Lee JK, "8-Oxo-2’-deoxyguanosine ameliorates UVB-induced skin damage in hairless mice by scavenging reactive oxygen species and inhibiting MMP expression", J Dermatol Sci, 70, pp.49~57 (2013)
- Ock CY, "A novel approach for stress-induced gastritis based on paradoxical anti-oxidative and anti-inflammatory action of exogenous 8-hydroxydeoxyguanosine", Biochem Pharmacol, 81, pp.111~122 (2011)
- Huh JY, "8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation", Free Radic Biol Med, 53, pp.109~121 (2012)
- Kim HS, "8-hydroxydeoxyguanosine suppresses NO production and COX-2 activity via Rac1", STATs signaling in LPS-induced brain microglia, 2006, pp.41, 1392~1403
- Lee SH, "Inhibition of Rac and Raclinked functions by 8-oxo-2’-deoxyguanosine in murine macrophages", Free Radic Res, 43, pp.78~84 (2009)
- Hordijk PL, "Regulation of NADPH oxidases : the role of Rac proteins", Circ Res, 98, pp.453~462 (2006)
- Bian F, "Inhibition of NLRP3 inflammasome pathway by butyrate improves corneal wound healing in corneal alkali burn", Int J Mol Sci, 18, pp.562~ (2017)
- Wang Y, "Topical calcitriol application promotes diabetic corneal wound healing and reinnervation through inhibiting NLRP3 inflammasome activation", Exp Eye Res, 209, pp.108668~ (2021)
- Zheng Q, "Reactive oxygen species activated NLRP3 inf lammasomes prime environment-induced murine dry eye", Exp Eye Res, 125, pp.1~8 (2014)
